Herbal medications and natural products for patients with covid-19 and diabetes mellitus: Potentials and challenges

Abdollahi, 2019, The effect of resveratrol supplementation on cardio-metabolic risk factors in patients with type 2 diabetes: a randomized, double-blind controlled trial, Phytother. Res., 33, 3153, 10.1002/ptr.6487 Abubakar, 2021, Natural products modulating angiotensin converting enzyme 2 (ACE2) as potential COVID-19 therapies, Front. Pharmacol., 12, 10.3389/fphar.2021.629935 Afsharpour, 2019, Propolis supplementation improves glycemic and antioxidant status in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study, Complement. Ther. Med., 43, 283, 10.1016/j.ctim.2019.03.001 Aghaz, 2021, Enhanced cryoprotective effect of melatonin and resveratrol by coencapsulation: improved in vitro development of vitrified-warmed mouse germinal vesicle oocytes, Biopreserv. Biobank., 19, 184, 10.1089/bio.2020.0102 Altobelli, 2021, Potential therapeutic effects of curcumin on glycemic and lipid profile in uncomplicated type 2 diabetes-a meta-analysis of randomized controlled trial, Nutrients, 13, 10.3390/nu13020404 Andrade, 2020, Medicinal plants utilized in Thai traditional medicine for diabetes treatment: ethnobotanical surveys, scientific evidence and phytochemicals, J. Ethnopharmacol., 263, 10.1016/j.jep.2020.113177 Ang, 2020, Herbal medicine for the treatment of coronavirus disease 2019 (Covid-19): a systematic review and meta-analysis of randomized controlled trials, J. Clin. Med., 9, 10.3390/jcm9051583 Astuti, 2020, Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2): an overview of viral structure and host response, Diabetes Metab. Syndr., 14, 407, 10.1016/j.dsx.2020.04.020 Augusti, 2021, Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: implications for covid-19, J. Nutr. Biochem., 10.1016/j.jnutbio.2021.108787 Ayeleso, 2017, Oleanolic acid and its derivatives: biological activities and therapeutic potential in chronic diseases, Molecules, 22, 1915, 10.3390/molecules22111915 Banihani, 2013, Pomegranate and type 2 diabetes, Nutr. Res., 33, 341, 10.1016/j.nutres.2013.03.003 Bernardi, 2020, Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain, PLoS One, 15, 10.1371/journal.pone.0237295 Berretta, 2020, Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease, Biomed. Pharmacother., 131, 10.1016/j.biopha.2020.110622 Bilal, 2018, Diabetic complications and insight into antidiabetic potentialities of ethnomedicinal plants: a review, Recent Pat. Inflamm. Allergy Drug Discov., 12, 7, 10.2174/1872213X12666180221161410 Böni-Schnetzler, 2019, Islet inflammation in type 2 diabetes, Semin. Immunopathol., 41, 501, 10.1007/s00281-019-00745-4 Borkotoky, 2021, A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem), J. Biomol. Struct. Dyn., 39, 4111, 10.1080/07391102.2020.1774419 Bornstein, 2020, Practical recommendations for the management of diabetes in patients with COVID-19, Lancet. Diabetes Endocrinol., 8, 546, 10.1016/S2213-8587(20)30152-2 Braxas, 2019, Effectiveness of genistein supplementation on metabolic factors and antioxidant status in postmenopausal women with type 2 diabetes mellitus, Can. J. Diabetes, 43, 490, 10.1016/j.jcjd.2019.04.007 Brufsky, 2020, Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic, J. Med. Virol., 92, 770, 10.1002/jmv.25887 Buetti, 2020, Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients, Endocrine, 70, 454, 10.1007/s12020-020-02465-4 Bustos, 2020, Interaction of quercetin and epigallocatechin gallate (EGCG) aggregates with pancreatic lipase under simplified intestinal conditions, PLoS One, 15, 10.1371/journal.pone.0224853 Carrera-Quintanar, 2018, Phytochemicals that influence gut microbiota as prophylactics and for the treatment of obesity and inflammatory diseases, Mediat. Inflamm., 2018, 10.1155/2018/9734845 Chan, 2020, COVID-19: an update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-western medicine for the management of 2019 novel coronavirus disease, Am. J. Chin. Med., 48, 737, 10.1142/S0192415X20500378 Chattopadhyay, 2021, SARS-CoV-2-indigenous microbiota nexus: does gut microbiota contribute to inflammation and disease severity in covid-19?, Front. Cell. Infect. Microbiol., 11, 10.3389/fcimb.2021.590874 Chen, 2020, T cell responses in patients with COVID-19, Nat. Rev. Immunol., 20, 529, 10.1038/s41577-020-0402-6 Cheng, 2020, Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus, J. Diabet. Compl., 107809 Cione, 2019, Quercetin, epigallocatechin gallate, curcumin, and resveratrol: from dietary sources to human MicroRNA modulation, Molecules, 25, 10.3390/molecules25010063 Couselo-Seijas, 2020, Higher ACE2 expression levels in epicardial than subcutaneous stromal cells from patients with cardiovascular disease: diabetes and obesity as possible enhancer, Eur. J. Clin. Invest Đambić, 2020, 3 Datta, 2020, SARS-CoV-2 pandemic and research gaps: understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy, Theranostics, 10, 7448, 10.7150/thno.48076 Davidson, 2020, Interaction of SARS-CoV-2 and other coronaviruses with ACE (angiotensin-converting enzyme)-2 as their main receptor: therapeutic implications, Hypertens, 76, 1339, 10.1161/HYPERTENSIONAHA.120.15256 de Almeida-Pititto, 2022, Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis, Diabetol. Metab. Syndr., 12, 75, 10.1186/s13098-020-00586-4 de Ligt, 2021, Resveratrol supplementation reduces ACE2 expression in human adipose tissue, Adipocyte, 10, 408, 10.1080/21623945.2021.1965315 Di Pierro, 2021, Potential clinical benefits of quercetin in the early stage of COVID-19: results of a second, pilot, randomized, controlled and open-label clinical trial, Int. J. Gen. Med., 10.2147/IJGM.S318949 Elfiky, 2021, Natural products may interfere with SARS-CoV-2 attachment to the host cell, J. Biomol. Struct. Dyn., 39, 3194 Erener, 2020, Diabetes, infection risk and COVID-19, Mol. Metab., 39, 10.1016/j.molmet.2020.101044 Fang, 2020, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet. Respir. Med., 8, e21, 10.1016/S2213-2600(20)30116-8 Feng, 2022, Yindan Jiedu granules exhibit anti-inflammatory effects in patients with novel Coronavirus disease (COVID-19) by suppressing the NF-κB signaling pathway, Phytomedicine, 95, 10.1016/j.phymed.2021.153784 Forcados, 2021, Metabolic implications of oxidative stress and inflammatory process in SARS-CoV-2 pathogenesis: therapeutic potential of natural antioxidants, Front. Cell. Infect. Microbiol., 11, 10.3389/fcimb.2021.654813 Fukui, 2003, Glycyrrhizin and serum testosterone concentrations in male patients with type 2 diabetes, Diabetes Care, 26, 2962, 10.2337/diacare.26.10.2962 Gavriatopoulou, 2020, Organ-specific manifestations of COVID-19 infection, Clin. Exp. Med., 20, 493, 10.1007/s10238-020-00648-x Gaziano, 2021, Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19, Nat. Med., 27, 668, 10.1038/s41591-021-01310-z Gheflati, 2021, The effects of propolis supplementation on metabolic parameters: a systematic review and meta-analysis of randomized controlled clinical trials, Avicenna J. Phytomed., 11, 551 Guo, 2020, Diabetes is a risk factor for the progression and prognosis of COVID-19, Diabetes. Metab. Res. Rev., e3319, 10.1002/dmrr.3319 Gurung, 2020, Role of gut microbiota in type 2 diabetes pathophysiology, EBioMedicine, 51, 10.1016/j.ebiom.2019.11.051 Hallajzadeh, 2021, Effects of propolis supplementation on glycemic status, lipid profiles, inflammation and oxidative stress, liver enzymes, and body weight: a systematic review and meta-analysis of randomized controlled clinical trials, J. Diabetes Metab. Disord., 20, 831, 10.1007/s40200-020-00696-w Hassaniazad, 2021, A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients, Phytother. Res., 35, 6417, 10.1002/ptr.7294 Herrmann, 2021, Extracellular vesicles as a next-generation drug delivery platform, Nat. Nanotechnol., 16, 748, 10.1038/s41565-021-00931-2 Homayouni, 2017, Hesperidin supplementation alleviates oxidative DNA damage and lipid peroxidation in type 2 diabetes: a randomized double-blind placebo-controlled clinical trial, Phytother. Res., 31, 1539, 10.1002/ptr.5881 Homayouni, 2018, Blood pressure lowering and anti-inflammatory effects of hesperidin in type 2 diabetes; a randomized double-blind controlled clinical trial, Phytother. Res., 32, 1073, 10.1002/ptr.6046 Hsueh, 2011, Renin-angiotensin-aldosterone system in diabetes and hypertension, J. Clin. Hypertens., 13, 224, 10.1111/j.1751-7176.2011.00449.x Hu, 2020, Characteristics of SARS-CoV-2 and COVID-19, Nat. Rev. Microbiol. Hu, 2018, Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection, Clin. Immunol., 195, 139, 10.1016/j.clim.2018.06.003 Jacob, 2019, Role of medicinal plants in the management of diabetes mellitus: a review, 3 Biotech, 9, 4, 10.1007/s13205-018-1528-0 Kasuga, 2021, Innate immune sensing of coronavirus and viral evasion strategies, Exp. Mol. Med., 53, 723, 10.1038/s12276-021-00602-1 Khajebishak, 2019, Effect of pomegranate seed oil supplementation on the GLUT-4 gene expression and glycemic control in obese people with type 2 diabetes: a randomized controlled clinical trial, J. Cell. Physiol., 234, 19621, 10.1002/jcp.28561 Kooti, 2016, The role of medicinal plants in the treatment of diabetes: a systematic review, Electron. Phys., 8, 1832, 10.19082/1832 Kosari, 2021, The effect of propolis plus Hyoscyamus niger L. methanolic extract on clinical symptoms in patients with acute respiratory syndrome suspected to COVID-19: a clinical trial, Phytother. Res., 35, 4000, 10.1002/ptr.7116 Kumar, 2021, Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches, J. Biomol. Struct. Dyn., 39, 3760, 10.1080/07391102.2020.1772112 Kumar, 2021, Herbal medicines for diabetes management and its secondary complications, Curr. Diabetes Rev., 17, 437, 10.2174/1573399816666201103143225 Lambert, 2010, Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in mice, Food Chem. Toxicol., 48, 409, 10.1016/j.fct.2009.10.030 Lee, 2020, Coronaviruses: innate immunity, inflammasome activation, inflammatory cell death, and cytokines, Trends Immunol., 41, 1083, 10.1016/j.it.2020.10.005 Li, 2021, Pharmacological activation of STING blocks SARS-CoV-2 infection, Sci. Immunol., 6, eabi9007, 10.1126/sciimmunol.abi9007 Li, 2021, Prolonged activation of innate immune pathways by a polyvalent STING agonist, Nat. Biomed. Eng., 5, 455, 10.1038/s41551-020-00675-9 Liang, 2020, Chinese herbal medicine used with or without conventional western therapy for COVID-19: an evidence review of clinical studies, Front. Pharmacol., 11 Lim, 2021, COVID-19 and diabetes mellitus: from pathophysiology to clinical management, Nat. Rev. Endocrinol., 17, 11, 10.1038/s41574-020-00435-4 Lim, 2021, Medicinal plants in covid-19: potential and limitations, Front. Pharmacol., 12, 355, 10.3389/fphar.2021.611408 Lowery, 2021, Innate immune and inflammatory responses to SARS-CoV-2: implications for COVID-19, Cell Host Microbe, 29, 1052, 10.1016/j.chom.2021.05.004 Major, 2020, Type I and III interferons disrupt lung epithelial repair during recovery from viral infection, Science, 369, 712, 10.1126/science.abc2061 Marín-Palma, 2021, Curcumin inhibits in vitro sars-cov-2 infection in vero e6 cells through multiple antiviral mechanisms, Molecules, 26, 6900, 10.3390/molecules26226900 Mashhadi, 2018, Astaxanthin improves glucose metabolism and reduces blood pressure in patients with type 2 diabetes mellitus, Asia Pac. J. Clin. Nutr., 27, 341 Mehdipour, 2021, Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike, Proc. Natl. Acad. Sci. U. S. A., 118, 10.1073/pnas.2100425118 Muniyappa, 2020, COVID-19 pandemic, coronaviruses, and diabetes mellitus, Am. J. Physiol. - Endocrinol. Metab., 318, E736, 10.1152/ajpendo.00124.2020 Ni, 2020, Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19, Crit. Care, 24, 422, 10.1186/s13054-020-03120-0 Oga, 2016, Pharmacokinetic herb-drug interactions: insight into mechanisms and consequences, Eur. J. Drug Metab. Pharmacokinet., 41, 93, 10.1007/s13318-015-0296-z Omrani, 2021, Potential natural products against respiratory viruses: a perspective to develop anti-covid-19 medicines, Front. Pharmacol., 11, 10.3389/fphar.2020.586993 Pang, 2019, Herbal medicine in the treatment of patients with type 2 diabetes mellitus, Chin. Med. J. (Engl)., 132, 78, 10.1097/CM9.0000000000000006 Pasquereau, 2021, Resveratrol inhibits HCoV-229e and SARS-CoV-2 coronavirus replication in vitro, Viruses, 13, 10.3390/v13020354 Patel, 2021, Virtual screening of curcumin and its analogs against the spike surface glycoprotein of SARS-CoV-2 and SARS-CoV, J. Biomol. Struct. Dyn., 1 Pawar, 2021, Molecular basis of quercetin as a plausible common denominator of macrophage-cholesterol-fenofibrate dependent potential COVID-19 treatment axis, Results Chem., 3, 10.1016/j.rechem.2021.100148 Pendyala, 2021, Phycobilins as potent food bioactive broad-spectrum inhibitors against proteases of SARS-CoV-2 and other coronaviruses: a preliminary study, Front. Microbiol., 12, 10.3389/fmicb.2021.645713 Qu, 2021, The potential effects of clinical antidiabetic agents on SARS-CoV-2, J. Diabetes, 13, 243, 10.1111/1753-0407.13135 Ragab, 2020, The COVID-19 cytokine storm; what we know so far, Front. Immunol., 11, 1446, 10.3389/fimmu.2020.01446 Ragheb, 2020, Impact of Rutin and Vitamin C combination on oxidative stress and glycemic control in patients with type 2 diabetes, Clin. Nutr. ESPEN, 35, 128, 10.1016/j.clnesp.2019.10.015 Rahman, 2021, Molecular docking analysis of rutin reveals possible inhibition of SARS-CoV-2 vital proteins, J. Tradit. Complement. Med., 11, 173, 10.1016/j.jtcme.2021.01.006 Ramírez-Alarcón, 2021, Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus, Front. Endocrinol., 12, 10.3389/fendo.2021.656978 Randeria, 2019, Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation, Cardiovasc. Diabetol., 18, 72, 10.1186/s12933-019-0870-9 Rao, 2020, Exploring diseases/traits and blood proteins causally related to the expression of ace2, the putative receptor of SARS-CoV-2: a mendelian randomization analysis highlights tentative relevance of diabetes-related traits, Diabetes Care, 43, 1416, 10.2337/dc20-0643 Refaat, 2021, Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19, Int. J. Pharm., 592, 10.1016/j.ijpharm.2020.120028 Saleh, 2021, The anti-inflammatory properties of phytochemicals and their effects on epigenetic mechanisms involved in TLR4/NF-κB-mediated inflammation, Front. Immunol., 12, 919, 10.3389/fimmu.2021.606069 Samadi, 2017, Effects of bee propolis supplementation on glycemic control, lipid profile and insulin resistance indices in patients with type 2 diabetes: a randomized, double-blind clinical trial, J. Integr. Med., 15, 124, 10.1016/S2095-4964(17)60315-7 Santos-Lozano, 2019, Prevention of type 2 diabetes in prediabetic patients by using functional olive oil enriched in oleanolic acid: The prediabole study, a randomized controlled trial, Diabetes. Obes. Metab., 21, 2526, 10.1111/dom.13838 Sette, 2021, Adaptive immunity to SARS-CoV-2 and COVID-19, Cell, 184, 861, 10.1016/j.cell.2021.01.007 Seyed Hashemi, 2021, Efficacy of pomegranate seed powder on glucose and lipid metabolism in patients with type 2 diabetes: a prospective randomized double-blind placebo-controlled clinical trial, Complement. Med. Res., 28, 226, 10.1159/000510986 Shanmugarajan, 2020, Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modeling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets, RSC Adv., 10, 31385, 10.1039/D0RA03167D Shi, 2019, In vitro and in vivo evidence that quercetin protects against diabetes and its complications: a systematic review of the literature, Biomed. Pharmacother., 109, 1085, 10.1016/j.biopha.2018.10.130 Shokri-Mashhadi, 2021, The antioxidant and anti-inflammatory effects of astaxanthin supplementation on the expression of miR-146a and miR-126 in patients with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled clinical trial, Int. J. Clin. Pract., 75, e14022, 10.1111/ijcp.14022 Shukla, 2021, Angiotensin-converting-enzyme 2 and renin-angiotensin system inhibitors in covid-19: an update, High Blood Press. Cardiovasc. Prev, 28, 129, 10.1007/s40292-021-00439-9 Silveira, 2021, Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial, Biomed. Pharmacother., 138, 10.1016/j.biopha.2021.111526 Soldo, 2020, Increased hepatic ACE2 expression in nafl and diabetes-a risk for covid-19 patients?, Diabetes Care, 10.2337/dc20-1458 Solnier, 2020, Flavonoids: a complementary approach to conventional therapy of COVID-19?, Phytochem. Rev., 6 Tabatabaie, 2020, The effect of resveratrol supplementation on serum levels of asymmetric de-methyl-arginine and paraoxonase 1 activity in patients with type 2 diabetes: a randomized, double-blind controlled trial, Phytother. Res., 34, 2023, 10.1002/ptr.6655 Tallei, 2020, Potential of plant bioactive compounds as SARS-CoV-2 main protease (M(pro)) and spike (S) glycoprotein inhibitors: a molecular docking study, Scientifica, 2020, 10.1155/2020/6307457 Thota, 2020, Dietary supplementation with curcumin reduces circulating levels of glycogen synthase kinase-3β and islet amyloid polypeptide in adults with a high risk of type 2 diabetes and Alzheimer's disease, Nutrients, 12, 10.3390/nu12041032 Tito, 2021, Pomegranate peel extract as an inhibitor of SARS-CoV-2 spike binding to human ACE2 receptor (in vitro): a promising source of novel antiviral drugs, Front. Chem., 9, 10.3389/fchem.2021.638187 Tsalamandris, 2019, The role of inflammation in diabetes: current concepts and future perspectives, Eur. Cardiol., 14, 50, 10.15420/ecr.2018.33.1 Tseng, 2020, Two hits to the renin-angiotensin system may play a key role in severe COVID-19, Kaohsiung J. Med. Sci., 36, 389, 10.1002/kjm2.12237 Urakaze, 2021, The beneficial effects of astaxanthin on glucose metabolism and modified low-density lipoprotein in healthy volunteers and subjects with prediabetes, Nutrients, 13, 10.3390/nu13124381 van de Sand, 2021, Glycyrrhizin effectively inhibits SARS-CoV-2 replication by inhibiting the viral main protease, Viruses, 13, 609, 10.3390/v13040609 Vlasova, 2019, Activation of interferon-α signaling by resveratrol, genistein and quercetin, Sib. J. Oncol., 18, 50, 10.21294/1814-4861-2019-18-1-50-55 2021 Wu, 2020, Analysis of the lymphocyte count in type 2 diabetic patients with coronavirus disease (COVID-19): A retrospective study in a centralized treatment center, Diabetes Res. Clin. Pract., 166, 10.1016/j.diabres.2020.108340 Wu, 2020, Advances in research on ACE2 as a receptor for 2019-nCoV, Cell. Mol. Life Sci. Xia, 2018, Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhance doxorubicin therapeutic efficacy in hepatocellular carcinoma, Biomed. Pharmacother., 99, 921, 10.1016/j.biopha.2018.01.163 Xia, 2021, Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study, Phytomedicine, 85, 10.1016/j.phymed.2020.153390 Xian, 2020, Bioactive natural compounds against human coronaviruses: a review and perspective, Acta Pharm. Sin. B, 10, 1163, 10.1016/j.apsb.2020.06.002 Xu, 2020, High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa, Int. J. Oral Sci., 12, 8, 10.1038/s41368-020-0074-x Yan, 2021, The potential role of extracellular vesicles in COVID-19 treatment: opportunity and challenge, Front. Mol. Biosci., 8, 10.3389/fmolb.2021.699929 Yang, 2020, Use of herbal drugs to treat COVID-19 should be with caution, Lancet, 395, 1689, 10.1016/S0140-6736(20)31143-0 Yao, 2019, Estimated daily quercetin intake and association with the prevalence of type 2 diabetes mellitus in Chinese adults, Eur. J. Nutr., 58, 819, 10.1007/s00394-018-1713-2 Ye, 2020, The pathogenesis and treatment of the `Cytokine Storm’ in COVID-19, J. Infect., 80, 607, 10.1016/j.jinf.2020.03.037 Zakerkish, 2019, The effect of Iranian propolis on glucose metabolism, lipid profile, insulin resistance, renal function and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind clinical trial, Sci. Rep., 9, 7289, 10.1038/s41598-019-43838-8 Zhang, 2021, The diversity of gut microbiota in type 2 diabetes with or without cognitive impairment, Aging Clin. Exp. Res., 33, 589, 10.1007/s40520-020-01553-9 Zhao, 2016, Brazilian green propolis improves antioxidant function in patients with Type 2 Diabetes mellitus, Int. J. Environ. Res. Public Health, 13, 10.3390/ijerph13050498 Zheng, 2020, Interactions between gut microbiota, host, and herbal medicines: a review of new insights into the pathogenesis and treatment of type 2 diabetes, Front. Cell. Infect. Microbiol., 10, 360, 10.3389/fcimb.2020.00360 Zhou, 2021, The effects of traditional Chinese medicine as an auxiliary treatment for COVID-19: a systematic review and meta-analysis, J. Altern. Complement. Med., 27, 225, 10.1089/acm.2020.0310 Zhou, 2020, Chloroquine against malaria, cancers and viral diseases, Drug Discov. Today, 25, 2012, 10.1016/j.drudis.2020.09.010 Zhu, 2017, Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis, Nutr. Metab., 14, 60, 10.1186/s12986-017-0217-z